Clovis Oncology Inc. sell dimontalban
Start price
06.04.22
/
50%
€2.64
Target price
06.04.23
€0.000
Performance (%)
-22.00%
End price
18.04.22
€2.06
Summary
This prediction ended on 18.04.22 with a price of €2.06. The price of Clovis Oncology Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -22.00%. dimontalban has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Clovis Oncology Inc. | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to dimontalban what are the pros and cons of Clovis Oncology Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Valuable balance sheet
Stable Large shareholder and/or long term investor
Sustainability is important
Cons
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Very low/no dividend yield expected
Junk rating
very negative Cash Flow expected
Little Investments for future growth
ROE lower than 5% per year
Increased challenges to pay loans and raise capital
Growths slower than the competition
Few uniques
Very bad culture
Deficits in Management
Very high cyclical dependencies
Little known brand
Business model of the past or high risk
High valuation
High risks for its business
Dependend from some customers or products
No Innovation
Below average Marketposition
Comments by dimontalban for this prediction
In the thread Clovis Oncology Inc. diskutieren
Sell mit Kursziel 0,0